Aller au contenu principal
Accès ouvert déclaré 2025 article

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis

50Citations signalées — pas une note de qualité
87Institutions déclarées
26Pays d’affiliation déclarés

Résumé fourni par la source

Importance: Progression independent of relapse activity (PIRA) is a significant contributor to long-term disability accumulation in relapsing-remitting multiple sclerosis (MS). Prior studies have used varying PIRA definitions, hampering the comparability of study results. Objective: To compare various definitions of PIRA. Design, Setting, and Participants: This cohort study involved a retrospective analysis of prospectively collected data from the MSBase registry from July 2004 to July 2023. The participants were patients with MS from 186 centers across 43 countries who had clinically definite relapsing-remitting MS, a complete minimal dataset, and 3 or more documented Expanded Disability Status Scale (EDSS) assessments. Exposure: Three-hundred sixty definitions of PIRA as combinations of the following criteria: baseline disability (fixed baseline with re-baselining after PIRA, or plus re-baselining after relapses, or plus re-baselining after improvements), minimum confirmation period (6, 12, or 24 months), confirmation magnitude (EDSS score at/above worsening score or at/above threshold compared with baseline), freedom from relapse at EDSS score worsening (90 days prior, 90 days prior and 30 days after, 180 days prior and after, since previous EDSS assessment, or since baseline), and freedom from relapse at confirmation (30 days prior, 90 days prior, 30 days before and after, or between worsening and confirmation). Main Outcome and Measure: For each definition, we quantified PIRA incidence and persistence (ie, absence of a 3-month confirmed EDSS improvement over ≥5 years). Results: Among 87 239 patients with MS, 33 303 patients fulfilled the inclusion criteria; 24 152 (72.5%) were female and 9151 (27.5%) were male. At the first visits, the mean (SD) age was 36.4 (10.9) years; 28 052 patients (84.2%) had relapsing-remitting MS, and the median (IQR) EDSS score was 2.0 (1.0-3.0). Participants had a mean (SD) 15.1 (11.9) visits over 8.9 (5.2) years. PIRA incidence ranged from 0.141 to 0.658 events per decade and persistence from 0.753 to 0.919, depending on the definition. In particular, the baseline and confirmation period influenced PIRA detection. The following definition yielded balanced incidence and persistence: a significant disability worsening compared with a baseline (reset after each PIRA event, relapse, and EDSS score improvement), in absence of relapses since the last EDSS assessment, confirmed with EDSS scores (not preceded by relapses within 30 days) that remained above the worsening threshold for at least 12 months. Conclusion and Relevance: Incidence and persistence of PIRA are determined by the definition used. The proposed standardized definition aims to enhance comparability among studies.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis
Date Crossref
01/06/2025
Éditeur
American Medical Association (AMA)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

The Royal Melbourne HospitalThe University of MelbourneUniversity of BaselUniversity Hospital of Baselİzmir University of EconomicsYeditepe University HospitalCharles UniversityJacobs InstituteIsfahan University of Medical SciencesAmiri HospitalPoliclinico Universitario di CataniaHospital Universitario Virgen MacarenaUniversité de MontréalIstituto delle Scienze Neurologiche di BolognaIstituti di Ricovero e Cura a Carattere ScientificoUniversity of BolognaUniversity of Chieti-PescaraThe University of Western AustraliaPerron Institute for Neurological and Translational ScienceDon Carlo Gnocchi FoundationUniversity of FlorenceHaydarpaşa Numune Eğitim ve Araştırma HastanesiKoç UniversityBox Hill HospitalEastern HealthMonash UniversityBakırköy Psychiatric HospitalThe Alfred HospitalHospital Clínic de BarcelonaMaastricht UniversityZuyderland Medisch CentrumAmerican University of Beirut Medical CenterMind AustraliaMonash HealthHunter Medical Research InstituteOspedale "Santa Maria delle Croci" di RavennaCliniques Universitaires Saint-LucCegep de Saint JeromeHospital de São JoãoOspedale CannizzaroUniversity of UlsterRoyal Victoria HospitalUNSW SydneyIngham InstituteSt. Vincent's University HospitalUniversity of MacerataRoyal Hobart HospitalAzienda Ospedaliera S.Giuseppe MoscatiFlinders UniversityThe University of QueenslandHôpital Razi de La ManoubaHospital Universitari Germans Trias i PujolUniversity Hospital Centre ZagrebUniversity of ZagrebHasselt UniversityHospital JihlavaAustin HealthHospital Clínico San CarlosInstituto de Investigación Sanitaria del Hospital Clínico San CarlosGroene Hart ZiekenhuisGhent University HospitalSt. Michael's HospitalWestmead HospitalSouth Eastern Health and Social Care TrustHospital Universitario Reina SofíaHospital de GaldakaoBiogipuzkoa Health Research InstituteAHEPA University HospitalAarhus University HospitalConcord Repatriation General HospitalSultan Qaboos University HospitalSultan Qaboos UniversityCamera de Comerț Industrie și Agricultură TimișoaraDRK Kamillus KlinikKing Fahad Specialist HospitalHospital Universitario AustralCentro de Educación Médica e Investigaciones Clínicas Norberto QuirnoHospital FernándezUniversity Hospital of GenevaAZ Sint-JanUniversity of DebrecenSt Vincent's Hospital MelbourneUniversity of AntwerpAntwerp University HospitalBarwon HealthAlmaSt Vincent's Hospital Sydney

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Multiple Sclerosis Research StudiesAmyotrophic Lateral Sclerosis ResearchBalance, Gait, and Falls Prevention

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.